Literature DB >> 27764468

Designing and Implementing an Early Literacy Screening Protocol: Suggestions for the Speech-Language Pathologist.

Laura M Justice1, Marcia A Invernizzi1, Joanne D Meier1.   

Abstract

The American Speech-Language-Hearing Association (2001) recently asserted that speech-language pathologists can and should play an important role in promoting literacy for young children with communicative impairments. Early literacy screening provides a valuable tool for speech-language pathologists to use for the timely detection of difficulties in literacy achievement. In addition, results of early literacy screening can be used to guide intervention and instruction. This article provides a rationale for incorporating early literacy screening into service delivery. It also makes recommendations for determining which children and what areas of literacy should be targeted in screening activities. Suggestions for interpreting findings are also provided, as are strategies for using screening to guide early literacy intervention.

Entities:  

Year:  2002        PMID: 27764468     DOI: 10.1044/0161-1461(2002/007)

Source DB:  PubMed          Journal:  Lang Speech Hear Serv Sch        ISSN: 0161-1461            Impact factor:   2.983


  3 in total

1.  Percent Grammatical Responses as a General Outcome Measure: Initial Validity.

Authors:  Sarita L Eisenberg; Ling-Yu Guo
Journal:  Lang Speech Hear Serv Sch       Date:  2018-01-09       Impact factor: 2.983

2.  Story time turbocharger? Child engagement during shared reading and cerebellar activation and connectivity in preschool-age children listening to stories.

Authors:  John S Hutton; Kieran Phelan; Tzipi Horowitz-Kraus; Jonathan Dudley; Mekibib Altaye; Thomas DeWitt; Scott K Holland
Journal:  PLoS One       Date:  2017-05-31       Impact factor: 3.240

3.  Shared reading quality assessment by parental report: preliminary validation of the DialogPR.

Authors:  John S Hutton; Guixia Huang; Kieran J Phelan; Thomas DeWitt; Richard F Ittenbach
Journal:  BMC Pediatr       Date:  2018-10-18       Impact factor: 2.125

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.